{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014882","form_type":"8-K","ticker":"BACK","cik":"0001729944","company_name":"IMAC Holdings, Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.779537+00:00","generated_at":"2026-06-03T22:19:57.369102+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"IMAC Holdings exchanges Series B preferred for Series C, raises $900k in PIPE","bullets":["Exchanged 4,550 Series B shares for 4,750 Series C-1 shares at $2.561 conversion price; old warrants exchanged for new.","PIPE sale of 1,276 Series C-2 shares and PIPE warrants netted ~$900k cash after settlement payments.","New warrants (Exchange, PIPE, Placement Agent) exercisable for ~2.62M shares at $2.561, expiring Oct 2029.","Company loans Theralink up to $1M (initial $350k at 9% cash/11% PIK), due Oct 12, 2024.","Company must seek shareholder approval by July 31, 2024 to avoid full-ratchet anti-dilution on preferred and warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014882","json":"https://secwatch.observer/filing/0001493152-24-014882.json","markdown":"https://secwatch.observer/filing/0001493152-24-014882.md","text":"https://secwatch.observer/filing/0001493152-24-014882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224014882/0001493152-24-014882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224014882/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:19:57.369102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d17f563c8e0a6e90b020f69a2c772a79a779a38d","claim":"IMAC Holdings, Inc. entered into Securities Purchase Agreement with accredited investors valued at aggregate cash proceeds ... of $900,000 (effective 2024-04-10).","evidence_excerpt":"the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, and the Investors agreed to purchase, 1,276 shares of Series C-2 convertible preferred stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224014882/0001493152-24-014882-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited investors"},{"label":"Value","value":"aggregate cash proceeds ... of $900,000"},{"label":"Effective","value":"2024-04-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}